Brain metastases in colorectal cancer: prognostic factors and survival analysis
Purpose Colorectal cancer (CRC) brain metastases (BM) are an uncommon and late event. We aim to investigate the impact of clinical factors, treatment modalities and RAS/BRAF status on the outcomes of CRC patients with BM. Patients We retrospectively analysed CRC patients who developed BM in our cent...
Saved in:
Published in: | International journal of colorectal disease Vol. 33; no. 11; pp. 1517 - 1523 |
---|---|
Main Authors: | , , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Berlin/Heidelberg
Springer Berlin Heidelberg
01-11-2018
Springer Springer Nature B.V |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Purpose
Colorectal cancer (CRC) brain metastases (BM) are an uncommon and late event. We aim to investigate the impact of clinical factors, treatment modalities and RAS/BRAF status on the outcomes of CRC patients with BM.
Patients
We retrospectively analysed CRC patients who developed BM in our centre between January 1997 and June 2017. Clinical factors, treatment modalities, RAS/BRAF status and survival were evaluated.
Results
Twenty-eight patients were recorded; 82% had left-sided (LS) CRC and 71% had lung metastases. Median time to BM diagnosis was 36 months (m) and 93% of patients received local treatment of BM (43% whole brain radiotherapy, 50% surgery). Right-sided (RS) CRC showed shorter time to BM, not previously described (9.3 vs 46.6 m for RS and LS CRC, respectively; HR = 4.7,
p
= 0.006). Median overall survival (mOS) from BM treatment was 9.5 m, better in patients who underwent surgery than those treated with radiotherapy alone (12.1 vs 4.6 m, respectively; HR = 0.3,
p
= 0.019) and in those without progressive metastatic extracranial disease (7.2 vs 20.9 m, for progressive and non-progressive, respectively; HR = 0.3,
p
= 0.056). Patients with two or more metastatic extracranial locations showed worse prognosis (5.9 vs 16.3 m, for > 2 vs 0–1, respectively; HR = 3.7,
p
= 0.015). RAS/BRAF status did not showed prognostic value.
Conclusions
Time to BM diagnosis is shorter in RS CRC. The presence of two or more metastatic extracranial locations and progressive metastatic extracranial disease at the time of BM diagnosis could be bad prognosis factors for CRC BM patients. |
---|---|
AbstractList | PURPOSEColorectal cancer (CRC) brain metastases (BM) are an uncommon and late event. We aim to investigate the impact of clinical factors, treatment modalities and RAS/BRAF status on the outcomes of CRC patients with BM.PATIENTSWe retrospectively analysed CRC patients who developed BM in our centre between January 1997 and June 2017. Clinical factors, treatment modalities, RAS/BRAF status and survival were evaluated.RESULTSTwenty-eight patients were recorded; 82% had left-sided (LS) CRC and 71% had lung metastases. Median time to BM diagnosis was 36 months (m) and 93% of patients received local treatment of BM (43% whole brain radiotherapy, 50% surgery). Right-sided (RS) CRC showed shorter time to BM, not previously described (9.3 vs 46.6 m for RS and LS CRC, respectively; HR = 4.7, p = 0.006). Median overall survival (mOS) from BM treatment was 9.5 m, better in patients who underwent surgery than those treated with radiotherapy alone (12.1 vs 4.6 m, respectively; HR = 0.3, p = 0.019) and in those without progressive metastatic extracranial disease (7.2 vs 20.9 m, for progressive and non-progressive, respectively; HR = 0.3, p = 0.056). Patients with two or more metastatic extracranial locations showed worse prognosis (5.9 vs 16.3 m, for > 2 vs 0-1, respectively; HR = 3.7, p = 0.015). RAS/BRAF status did not showed prognostic value.CONCLUSIONSTime to BM diagnosis is shorter in RS CRC. The presence of two or more metastatic extracranial locations and progressive metastatic extracranial disease at the time of BM diagnosis could be bad prognosis factors for CRC BM patients. Purpose Colorectal cancer (CRC) brain metastases (BM) are an uncommon and late event. We aim to investigate the impact of clinical factors, treatment modalities and RAS/BRAF status on the outcomes of CRC patients with BM. Patients We retrospectively analysed CRC patients who developed BM in our centre between January 1997 and June 2017. Clinical factors, treatment modalities, RAS/BRAF status and survival were evaluated. Results Twenty-eight patients were recorded; 82% had left-sided (LS) CRC and 71% had lung metastases. Median time to BM diagnosis was 36 months (m) and 93% of patients received local treatment of BM (43% whole brain radiotherapy, 50% surgery). Right-sided (RS) CRC showed shorter time to BM, not previously described (9.3 vs 46.6 m for RS and LS CRC, respectively; HR = 4.7, p = 0.006). Median overall survival (mOS) from BM treatment was 9.5 m, better in patients who underwent surgery than those treated with radiotherapy alone (12.1 vs 4.6 m, respectively; HR = 0.3, p = 0.019) and in those without progressive metastatic extracranial disease (7.2 vs 20.9 m, for progressive and non-progressive, respectively; HR = 0.3, p = 0.056). Patients with two or more metastatic extracranial locations showed worse prognosis (5.9 vs 16.3 m, for > 2 vs 0–1, respectively; HR = 3.7, p = 0.015). RAS/BRAF status did not showed prognostic value. Conclusions Time to BM diagnosis is shorter in RS CRC. The presence of two or more metastatic extracranial locations and progressive metastatic extracranial disease at the time of BM diagnosis could be bad prognosis factors for CRC BM patients. Colorectal cancer (CRC) brain metastases (BM) are an uncommon and late event. We aim to investigate the impact of clinical factors, treatment modalities and RAS/BRAF status on the outcomes of CRC patients with BM. We retrospectively analysed CRC patients who developed BM in our centre between January 1997 and June 2017. Clinical factors, treatment modalities, RAS/BRAF status and survival were evaluated. Twenty-eight patients were recorded; 82% had left-sided (LS) CRC and 71% had lung metastases. Median time to BM diagnosis was 36 months (m) and 93% of patients received local treatment of BM (43% whole brain radiotherapy, 50% surgery). Right-sided (RS) CRC showed shorter time to BM, not previously described (9.3 vs 46.6 m for RS and LS CRC, respectively; HR = 4.7, p = 0.006). Median overall survival (mOS) from BM treatment was 9.5 m, better in patients who underwent surgery than those treated with radiotherapy alone (12.1 vs 4.6 m, respectively; HR = 0.3, p = 0.019) and in those without progressive metastatic extracranial disease (7.2 vs 20.9 m, for progressive and non-progressive, respectively; HR = 0.3, p = 0.056). Patients with two or more metastatic extracranial locations showed worse prognosis (5.9 vs 16.3 m, for > 2 vs 0-1, respectively; HR = 3.7, p = 0.015). RAS/BRAF status did not showed prognostic value. Time to BM diagnosis is shorter in RS CRC. The presence of two or more metastatic extracranial locations and progressive metastatic extracranial disease at the time of BM diagnosis could be bad prognosis factors for CRC BM patients. Colorectal cancer (CRC) brain metastases (BM) are an uncommon and late event. We aim to investigate the impact of clinical factors, treatment modalities and RAS/BRAF status on the outcomes of CRC patients with BM. We retrospectively analysed CRC patients who developed BM in our centre between January 1997 and June 2017. Clinical factors, treatment modalities, RAS/BRAF status and survival were evaluated. Twenty-eight patients were recorded; 82% had left-sided (LS) CRC and 71% had lung metastases. Median time to BM diagnosis was 36 months (m) and 93% of patients received local treatment of BM (43% whole brain radiotherapy, 50% surgery). Right-sided (RS) CRC showed shorter time to BM, not previously described (9.3 vs 46.6 m for RS and LS CRC, respectively; HR = 4.7, p = 0.006). Median overall survival (mOS) from BM treatment was 9.5 m, better in patients who underwent surgery than those treated with radiotherapy alone (12.1 vs 4.6 m, respectively; HR = 0.3, p = 0.019) and in those without progressive metastatic extracranial disease (7.2 vs 20.9 m, for progressive and non-progressive, respectively; HR = 0.3, p = 0.056). Patients with two or more metastatic extracranial locations showed worse prognosis (5.9 vs 16.3 m, for > 2 vs 0-1, respectively; HR = 3.7, p = 0.015). RAS/BRAF status did not showed prognostic value. Time to BM diagnosis is shorter in RS CRC. The presence of two or more metastatic extracranial locations and progressive metastatic extracranial disease at the time of BM diagnosis could be bad prognosis factors for CRC BM patients. PurposeColorectal cancer (CRC) brain metastases (BM) are an uncommon and late event. We aim to investigate the impact of clinical factors, treatment modalities and RAS/BRAF status on the outcomes of CRC patients with BM.PatientsWe retrospectively analysed CRC patients who developed BM in our centre between January 1997 and June 2017. Clinical factors, treatment modalities, RAS/BRAF status and survival were evaluated.ResultsTwenty-eight patients were recorded; 82% had left-sided (LS) CRC and 71% had lung metastases. Median time to BM diagnosis was 36 months (m) and 93% of patients received local treatment of BM (43% whole brain radiotherapy, 50% surgery). Right-sided (RS) CRC showed shorter time to BM, not previously described (9.3 vs 46.6 m for RS and LS CRC, respectively; HR = 4.7, p = 0.006). Median overall survival (mOS) from BM treatment was 9.5 m, better in patients who underwent surgery than those treated with radiotherapy alone (12.1 vs 4.6 m, respectively; HR = 0.3, p = 0.019) and in those without progressive metastatic extracranial disease (7.2 vs 20.9 m, for progressive and non-progressive, respectively; HR = 0.3, p = 0.056). Patients with two or more metastatic extracranial locations showed worse prognosis (5.9 vs 16.3 m, for > 2 vs 0–1, respectively; HR = 3.7, p = 0.015). RAS/BRAF status did not showed prognostic value.ConclusionsTime to BM diagnosis is shorter in RS CRC. The presence of two or more metastatic extracranial locations and progressive metastatic extracranial disease at the time of BM diagnosis could be bad prognosis factors for CRC BM patients. Purpose Colorectal cancer (CRC) brain metastases (BM) are an uncommon and late event. We aim to investigate the impact of clinical factors, treatment modalities and RAS/BRAF status on the outcomes of CRC patients with BM. Patients We retrospectively analysed CRC patients who developed BM in our centre between January 1997 and June 2017. Clinical factors, treatment modalities, RAS/BRAF status and survival were evaluated. Results Twenty-eight patients were recorded; 82% had left-sided (LS) CRC and 71% had lung metastases. Median time to BM diagnosis was 36 months (m) and 93% of patients received local treatment of BM (43% whole brain radiotherapy, 50% surgery). Right-sided (RS) CRC showed shorter time to BM, not previously described (9.3 vs 46.6 m for RS and LS CRC, respectively; HR = 4.7, p = 0.006). Median overall survival (mOS) from BM treatment was 9.5 m, better in patients who underwent surgery than those treated with radiotherapy alone (12.1 vs 4.6 m, respectively; HR = 0.3, p = 0.019) and in those without progressive metastatic extracranial disease (7.2 vs 20.9 m, for progressive and non-progressive, respectively; HR = 0.3, p = 0.056). Patients with two or more metastatic extracranial locations showed worse prognosis (5.9 vs 16.3 m, for > 2 vs 0-1, respectively; HR = 3.7, p = 0.015). RAS/BRAF status did not showed prognostic value. Conclusions Time to BM diagnosis is shorter in RS CRC. The presence of two or more metastatic extracranial locations and progressive metastatic extracranial disease at the time of BM diagnosis could be bad prognosis factors for CRC BM patients. |
Audience | Academic |
Author | Andres Granyo, Marta Virgili Manrique, Anna Cristina Barnadas Molins, Agusti Martin-Richard, Marta Del Carpio Huerta, Luis Paez Lopez-Bravo, David Espinosa Mariscal, Iñigo Gomila Pons, Paula Sebio Garcia, Ana Szafranska, Justyna Barba Joaquin, Andres Tobeña Puyal, Maria |
Author_xml | – sequence: 1 givenname: Luis orcidid: 0000-0001-9017-2460 surname: Del Carpio Huerta fullname: Del Carpio Huerta, Luis email: Lcarpio@santpau.cat organization: Medical Oncology Department, Santa Creu i Sant Pau Hospital – sequence: 2 givenname: Anna Cristina surname: Virgili Manrique fullname: Virgili Manrique, Anna Cristina organization: Medical Oncology Department, Santa Creu i Sant Pau Hospital – sequence: 3 givenname: Justyna surname: Szafranska fullname: Szafranska, Justyna organization: Pathology Department, Santa Creu i Sant Pau Hospital – sequence: 4 givenname: Marta surname: Martin-Richard fullname: Martin-Richard, Marta organization: Medical Oncology Department, Santa Creu i Sant Pau Hospital – sequence: 5 givenname: David surname: Paez Lopez-Bravo fullname: Paez Lopez-Bravo, David organization: Medical Oncology Department, Santa Creu i Sant Pau Hospital – sequence: 6 givenname: Ana surname: Sebio Garcia fullname: Sebio Garcia, Ana organization: Medical Oncology Department, Santa Creu i Sant Pau Hospital – sequence: 7 givenname: Iñigo surname: Espinosa Mariscal fullname: Espinosa Mariscal, Iñigo organization: Pathology Department, Santa Creu i Sant Pau Hospital – sequence: 8 givenname: Paula surname: Gomila Pons fullname: Gomila Pons, Paula organization: Medical Oncology Department, Santa Creu i Sant Pau Hospital – sequence: 9 givenname: Marta surname: Andres Granyo fullname: Andres Granyo, Marta organization: Medical Oncology Department, Santa Creu i Sant Pau Hospital – sequence: 10 givenname: Andres surname: Barba Joaquin fullname: Barba Joaquin, Andres organization: Medical Oncology Department, Santa Creu i Sant Pau Hospital – sequence: 11 givenname: Agusti surname: Barnadas Molins fullname: Barnadas Molins, Agusti organization: Medical Oncology Department, Santa Creu i Sant Pau Hospital – sequence: 12 givenname: Maria surname: Tobeña Puyal fullname: Tobeña Puyal, Maria email: Mtobena@santpau.cat organization: Medical Oncology Department, Santa Creu i Sant Pau Hospital |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29943356$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kU1LHTEYhYNY6tX2B7iRgW66GZvvj-6sVC0Ibtp1yM28uURmEpvMCP775nq1orQkEN7kOYcTziHaTzkBQscEnxKM1ZeKMdO8x0T3jGDVyz20IpzRnlBJ99EKE2V6YoQ-QIe13uI2S8XfowNqDGdMyBW6-VZcTN0Es6ttQ-3a5POYC_jZjZ13yUP52t2VvEm5ztF3wfk5l9q5NHR1KffxvnEuufGhxvoBvQturPDx6TxCvy6-_zy_6q9vLn-cn133njMz93qtCGOGCoaVGwRfCyaFZACMBd3CYwhKCjNwIumaMu314JwkAcAICI06Qp93vi3Y7wXqbKdYPYyjS5CXaikWRnCjOGnopzfobV5Ky_tIac05VviF2rgRbEwhz8X5rak9U4RzrRnfUqf_oNoaYIq-tRNiu38lIDuBL7nWAsHelTi58mAJttsS7a5E20q02xKtbJqTp8DLeoLhr-K5tQbQHVDbU9pAefnR_13_ADr-plU |
CitedBy_id | crossref_primary_10_3862_jcoloproctology_75_44 crossref_primary_10_5582_bst_2019_01044 crossref_primary_10_1007_s00384_019_03306_1 crossref_primary_10_1016_j_semcancer_2019_10_010 crossref_primary_10_2147_CMAR_S320179 crossref_primary_10_3390_diagnostics12071586 crossref_primary_10_1186_s40792_022_01407_8 crossref_primary_10_1259_bjr_20200951 crossref_primary_10_3389_fmed_2022_768896 crossref_primary_10_3390_cancers13040900 |
Cites_doi | 10.1097/01.dcr.0000436998.30504.98 10.1007/s11060-010-0214-9 10.1002/jso.23055 10.1093/annonc/mdu275 10.7314/APJCP.2016.17.4.2545 10.1007/s00384-013-1781-y 10.1007/s12094-015-1341-8 10.1159/000478661 10.1016/j.ijrobp.2008.12.031 10.3322/caac.21387 10.1111/ans.14107 10.1007/s10151-017-1707-8 10.1038/s41598-017-08413-z 10.1001/jamaoncol.2016.4227 10.1007/s12094-015-1340-9 10.1002/cncr.23531 10.1016/j.canrad.2013.12.003 10.3748/wjg.v21.i41.11767 10.1002/cncr.29196 10.1016/j.ejca.2017.07.016 10.1016/j.clcc.2015.05.009 10.21037/jgo.2016.12.11 10.2217/fon-2016-0196 10.1007/s12032-014-0152-z 10.1016/j.clcc.2014.09.008 10.4161/cbt.28550 10.1080/0284186X.2017.1290272 10.1186/1756-9966-30-10 10.1007/s11845-015-1272-y 10.3816/CCC.2009.n.016 |
ContentType | Journal Article |
Copyright | Springer-Verlag GmbH Germany, part of Springer Nature 2018 COPYRIGHT 2018 Springer International Journal of Colorectal Disease is a copyright of Springer, (2018). All Rights Reserved. |
Copyright_xml | – notice: Springer-Verlag GmbH Germany, part of Springer Nature 2018 – notice: COPYRIGHT 2018 Springer – notice: International Journal of Colorectal Disease is a copyright of Springer, (2018). All Rights Reserved. |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7T5 7X7 7XB 88E 8AO 8FI 8FJ 8FK ABUWG AFKRA BENPR CCPQU FYUFA GHDGH H94 K9. M0S M1P PQEST PQQKQ PQUKI 7X8 |
DOI | 10.1007/s00384-018-3107-6 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) Immunology Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central ProQuest One Community College Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Pharma Collection ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest Medical Library ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) AIDS and Cancer Research Abstracts Immunology Abstracts ProQuest One Academic ProQuest Medical Library (Alumni) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE ProQuest One Academic Eastern Edition |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1432-1262 |
EndPage | 1523 |
ExternalDocumentID | A714488340 10_1007_s00384_018_3107_6 29943356 |
Genre | Journal Article |
GroupedDBID | --- -53 -5E -5G -BR -EM -Y2 -~C .86 .GJ .VR 06C 06D 0R~ 0VY 1N0 1SB 2.D 203 28- 29J 29~ 2J2 2JN 2JY 2KG 2LR 2P1 2VQ 2~H 30V 36B 3V. 4.4 406 408 409 40D 40E 53G 5GY 5QI 5RE 5VS 67Z 6NX 7X7 88E 8AO 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AABYN AAFGU AAHNG AAIAL AAJKR AAKSU AANXM AANZL AAPBV AARHV AARTL AATNV AATVU AAUYE AAWCG AAYFA AAYIU AAYQN AAYTO ABBBX ABBXA ABDZT ABECU ABFGW ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKAS ABKCH ABKTR ABMNI ABMQK ABNWP ABOCM ABPLI ABPTK ABQBU ABSXP ABTEG ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACBMV ACBRV ACBXY ACBYP ACGFS ACHSB ACHXU ACIGE ACIPQ ACKNC ACMDZ ACMLO ACOKC ACOMO ACPRK ACTTH ACUDM ACVWB ACWMK ADBBV ADHHG ADHIR ADINQ ADJJI ADKNI ADKPE ADMDM ADOXG ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEEQQ AEFIE AEFTE AEGAL AEGNC AEJHL AEJRE AEKMD AENEX AEOHA AEPYU AESKC AESTI AETLH AEVLU AEVTX AEXYK AFAFS AFDYV AFEXP AFKRA AFLOW AFNRJ AFQWF AFWTZ AFZKB AGAYW AGDGC AGGBP AGGDS AGJBK AGKHE AGMZJ AGQMX AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHMBA AHSBF AHYZX AIAKS AIIXL AILAN AIMYW AITGF AJBLW AJDOV AJRNO AJZVZ AKMHD AKQUC ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN B-. BA0 BBWZM BDATZ BENPR BGNMA BPHCQ BVXVI CAG CCPQU COF CS3 CSCUP DDRTE DL5 DNIVK DPUIP DU5 EBD EBLON EBS EIOEI EJD EMB EMOBN EN4 ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GQ8 GRRUI GXS HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IAO IHE IHR IJ- IKXTQ IMOTQ ITM IWAJR IXC IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KOW KPH LAS LLZTM M1P M4Y MA- N2Q N9A NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM P19 P9S PF0 PQQKQ PROAC PSQYO PT4 PT5 Q2X QOK QOR QOS R4E R89 R9I RHV RIG RNI ROL RPX RRX RSV RZK S16 S1Z S26 S27 S28 S37 S3B SAP SCLPG SDE SDH SDM SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 T16 TSG TSK TSV TT1 TUC U2A U9L UG4 UKHRP UNUBA UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK8 YLTOR Z45 Z7U Z7V Z7W Z7X Z82 Z87 Z8O Z8P Z8Q Z8V Z91 ZMTXR ZOVNA ~EX ~KM AAEOY AAKKN AAYZH ABAKF ABEEZ ACACY ACULB ACZOJ AEFQL AFBBN AFGXO AGQEE AGRTI AJOOF ALIPV C24 C6C CGR CUY CVF ECM EIF H13 NPM AAYXX CITATION 7T5 7XB 8FK H94 K9. PQEST PQUKI 7X8 |
ID | FETCH-LOGICAL-c439t-8b7133925307ad54b536563ee33f82620ef7659d4162b238c8daa61fee95efe33 |
IEDL.DBID | AEJHL |
ISSN | 0179-1958 |
IngestDate | Sat Oct 26 00:38:02 EDT 2024 Wed Nov 06 08:31:09 EST 2024 Tue Nov 19 21:17:00 EST 2024 Tue Nov 12 22:50:58 EST 2024 Thu Nov 21 21:28:34 EST 2024 Wed Oct 16 00:50:37 EDT 2024 Sat Dec 16 12:00:36 EST 2023 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 11 |
Keywords | Brain metastases Colorectal cancer location Whole brain radiotherapy Surgery Colorectal cancer |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c439t-8b7133925307ad54b536563ee33f82620ef7659d4162b238c8daa61fee95efe33 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0001-9017-2460 |
PMID | 29943356 |
PQID | 2058844070 |
PQPubID | 31377 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_2059549741 proquest_journals_2058844070 gale_infotracmisc_A714488340 gale_infotracacademiconefile_A714488340 crossref_primary_10_1007_s00384_018_3107_6 pubmed_primary_29943356 springer_journals_10_1007_s00384_018_3107_6 |
PublicationCentury | 2000 |
PublicationDate | 2018-11-01 |
PublicationDateYYYYMMDD | 2018-11-01 |
PublicationDate_xml | – month: 11 year: 2018 text: 2018-11-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Berlin/Heidelberg |
PublicationPlace_xml | – name: Berlin/Heidelberg – name: Germany – name: New York |
PublicationSubtitle | Clinical and Molecular Gastroenterology and Surgery |
PublicationTitle | International journal of colorectal disease |
PublicationTitleAbbrev | Int J Colorectal Dis |
PublicationTitleAlternate | Int J Colorectal Dis |
PublicationYear | 2018 |
Publisher | Springer Berlin Heidelberg Springer Springer Nature B.V |
Publisher_xml | – name: Springer Berlin Heidelberg – name: Springer – name: Springer Nature B.V |
References | Fausto Petrelli, Gianluca Tomasello, Karen Borgonovo, Michele Ghidini, Luca Turati, PierpaoloDallera, Rodolfo Passalacqua, Giovanni Sgroi, Sandro Barni (CR20) 2016; 3 Lin, Zhao, Ge, Wang, Chen, Liu, Jia, Liu, Liu, Xu (CR22) 2016; 18 Vatandoust, Price, Karapetis (CR31) 2015; 21 Feuvret, Vinchon, Martin, Lamproglou, Halley, Calugaru, Chea, Valéry, Simon, Mazeron (CR30) 2014; 18 Christensen, Palshof, Larsen, Høgdall, Poulsen, Pfeiffer, Jensen, Yilmaz, Christensen, Nielsen (CR10) 2017; 56 Hussain, Waqas, Hassan (CR19) 2016; 17 Siegel, Miller, Jemal (CR1) 2017; 67 Kased, Binder, McDermott (CR29) 2009; 75 Kruser, Chao, Elson, Barnett, Vogelbaum, Angelov, Weil, Pelley, Suh (CR4) 2008; 113 Suzuki, Yamaguchi, Matsumoto, Nakano, Honda, Shinoura, Karasawa, Takahashi (CR8) 2014; 57 Nozawa, Ishihara, Kawai, Sasaki, Murono, Otani, Nishikawa, Tanaka, Kiyomatsu, Hata, Watanabe (CR24) 2017; 93 Fountzilas, Chang, Hernandez, Michalek, Crownover, Floyd, Mahalingam (CR5) 2017; 8 Tanriverdi, Kaytan-Saglam, Ulger, Bayoglu, Turker, Ozturk-Topcu, Cokmert, Turhal, Oktay, Karabulut, Kilic, Kucukzeybek, Oksuzoglu, Meydan, Kaya, Akman, Ibis, Saynak, Sen, Uysal-Sonmez, Pilancı, Demir, Saglam, Kocar, Menekse, Goksel, Yapar-Taskoylu, Yaren, Uyeturk, Avci, Denizli, Ilis-Temiz (CR3) 2014; 31 Gaspar, Scott, Rotman (CR13) 1997; 37 Tong, Lung, Sin, Law, Kang, Chan, Ma, Mak, Ng, To (CR15) 2014; 15 Yaeger, Cowell, Chou, Gewirtz, Borsu, Vakiani, Solit, Rosen, Capanu, Ladanyi, Kemeny (CR12) 2015; 121 Gao, Yu, Gong, Liu, Xu, Hao, Liu, Liu, Bai, Zhang (CR17) 2017; 7 Fabi, Felici, Metro, Mirri, Bria, Telera, Moscetti, Russillo, Lanzetta, Mansueto, Pace, Maschio, Vidiri, Sperduti, Cognetti, Carapella (CR2) 2011; 30 Michl, Thurmaier, Schubert-Fritschle, Wiedemann, Laubender, Nüssler, Ruppert, Kleeff, Schepp, Reuter, Löhe, Karthaus, Neumann, Kirchner, Engel, Heinemann (CR9) 2015; 14 Missiaglia, Jacobs, D’Ario (CR16) 2014; 25 Mege, Sans, Ouaissi, Iannelli, Sielezneff (CR28) 2017; 88 Stintzing, Tejpar, Gibbs, Thiebach (CR18) 2017; 84 Nieder, Hintz, Grosu (CR27) 2016; 18 Aprile, Casagrande, De Maglio (CR25) 2017; 13 Silva, Iskandarani, Hotouras, Murphy, Bhan, Adada, Wexner (CR14) 2017; 21 Tevlin, Larkin, Hyland, O’Connell, Winter (CR7) 2015; 184 Tokoro, Okuno, Hida, Ueda, Yoshifuji, Daito, Sugiura (CR11) 2014; 13 Magni, Santoro, Ravenda, Leonardi, Bonomo, Monfardini, Nolè, Zampino (CR21) 2014; 29 Mongan, Fadul, Cole, Zaki, Suriawinata, Ripple, Tosteson, Pipas (CR23) 2009; 8 Noura, Ohue, Shingai, Fujiwara, Imada, Sueda, Yamada, Fujiwara, Ohigashi, Yano, Ishikawa (CR6) 2012; 106 Jung, Ahn, Chang, Suh, Hong, Roh, Shin, Rha (CR26) 2011; 101 C Nieder (3107_CR27) 2016; 18 E Missiaglia (3107_CR16) 2014; 25 E Magni (3107_CR21) 2014; 29 M Jung (3107_CR26) 2011; 101 XH Gao (3107_CR17) 2017; 7 R Tevlin (3107_CR7) 2015; 184 N Kased (3107_CR29) 2009; 75 Yozo Suzuki (3107_CR8) 2014; 57 H Nozawa (3107_CR24) 2017; 93 S Vatandoust (3107_CR31) 2015; 21 MD Fausto Petrelli (3107_CR20) 2016; 3 L Lin (3107_CR22) 2016; 18 L Feuvret (3107_CR30) 2014; 18 A Fabi (3107_CR2) 2011; 30 G Aprile (3107_CR25) 2017; 13 M Michl (3107_CR9) 2015; 14 R Yaeger (3107_CR12) 2015; 121 O Tanriverdi (3107_CR3) 2014; 31 RL Siegel (3107_CR1) 2017; 67 TD Christensen (3107_CR10) 2017; 56 JP Mongan (3107_CR23) 2009; 8 T Tokoro (3107_CR11) 2014; 13 S Noura (3107_CR6) 2012; 106 D Mege (3107_CR28) 2017; 88 TJ Kruser (3107_CR4) 2008; 113 S Stintzing (3107_CR18) 2017; 84 C Fountzilas (3107_CR5) 2017; 8 L Gaspar (3107_CR13) 1997; 37 JHM Tong (3107_CR15) 2014; 15 M Hussain (3107_CR19) 2016; 17 IL Silva (3107_CR14) 2017; 21 |
References_xml | – volume: 57 start-page: 56 issue: 1 year: 2014 end-page: 63 ident: CR8 article-title: Prognostic Factors and Treatment Effects in Patients With Curatively Resected Brain Metastasis From Colorectal Cancer publication-title: Diseases of the Colon & Rectum doi: 10.1097/01.dcr.0000436998.30504.98 contributor: fullname: Takahashi – volume: 101 start-page: 49 year: 2011 end-page: 55 ident: CR26 article-title: Brain metastases from colorectal carcinoma: prognostic factors and outcome publication-title: J Neuro-Oncol doi: 10.1007/s11060-010-0214-9 contributor: fullname: Rha – volume: 106 start-page: 144 year: 2012 end-page: 148 ident: CR6 article-title: Brain metastasis from colorectal cancer: prognostic factors and survival publication-title: J Surg Oncol doi: 10.1002/jso.23055 contributor: fullname: Ishikawa – volume: 25 start-page: 1995 year: 2014 end-page: 2001 ident: CR16 article-title: Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical features publication-title: Ann Oncol doi: 10.1093/annonc/mdu275 contributor: fullname: D’Ario – volume: 17 start-page: 2545 year: 2016 end-page: 2548 ident: CR19 article-title: Right-sided and left-sided colon cancers are two distinct disease entities: an analysis of 200 cases in Pakistan publication-title: Asian Pacific J Cancer Prev doi: 10.7314/APJCP.2016.17.4.2545 contributor: fullname: Hassan – volume: 29 start-page: 201 year: 2014 end-page: 208 ident: CR21 article-title: Brain metastases from colorectal cancer: main clinical factors conditioning outcome publication-title: Int J Color Dis doi: 10.1007/s00384-013-1781-y contributor: fullname: Zampino – volume: 18 start-page: 93 year: 2016 end-page: 98 ident: CR22 article-title: Patients with brain metastases derived from gastrointestinal cancer: clinical characteristics and prognostic factors publication-title: Clin Transl Oncol doi: 10.1007/s12094-015-1341-8 contributor: fullname: Xu – volume: 93 start-page: 309 year: 2017 end-page: 314 ident: CR24 article-title: Brain metastasis from colorectal cancer: predictors and treatment outcomes publication-title: Oncology doi: 10.1159/000478661 contributor: fullname: Watanabe – volume: 75 start-page: 1132 year: 2009 end-page: 1140 ident: CR29 article-title: Gamma Knife radiosurgery for brain metastases from primary breast cancer publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/j.ijrobp.2008.12.031 contributor: fullname: McDermott – volume: 67 start-page: 7 year: 2017 end-page: 30 ident: CR1 article-title: Cancer statistics, 2017 publication-title: CA Cancer J Clin doi: 10.3322/caac.21387 contributor: fullname: Jemal – volume: 88 start-page: 140 year: 2017 end-page: 145 ident: CR28 article-title: Brain metastases from colorectal cancer: characteristics and management publication-title: ANZ J Surg doi: 10.1111/ans.14107 contributor: fullname: Sielezneff – volume: 21 start-page: 847 year: 2017 end-page: 852 ident: CR14 article-title: A systematic review to assess the management of patients with cerebral metastases secondary to colorectal cancer publication-title: Tech Coloproctol doi: 10.1007/s10151-017-1707-8 contributor: fullname: Wexner – volume: 7 year: 2017 ident: CR17 article-title: Differences of protein expression profiles, KRAS and BRAF mutation, and prognosis in right-sided colon, left-sided colon and rectal cancer publication-title: Sci Rep doi: 10.1038/s41598-017-08413-z contributor: fullname: Zhang – volume: 3 start-page: 1 year: 2016 end-page: 9 ident: CR20 article-title: Prognostic survival associated with left-sided vs right-sided Colon Cancer a systematic review and meta-analysis publication-title: Jama Oncol doi: 10.1001/jamaoncol.2016.4227 contributor: fullname: Sandro Barni – volume: 18 start-page: 88 year: 2016 end-page: 92 ident: CR27 article-title: Colorectal cancer metastatic to the brain: analysis of prognostic factors and impact of KRAS mutations on presentation and outcome publication-title: Clin Transl Oncol doi: 10.1007/s12094-015-1340-9 contributor: fullname: Grosu – volume: 113 start-page: 158 year: 2008 end-page: 165 ident: CR4 article-title: Multidisciplinary management of colorectal brain metastases: a retrospective study publication-title: Cancer doi: 10.1002/cncr.23531 contributor: fullname: Suh – volume: 18 start-page: 97 year: 2014 end-page: 106 ident: CR30 article-title: Stereotactic radiotherapy for large solitary brain metastases publication-title: Cancer/Radiotherapie doi: 10.1016/j.canrad.2013.12.003 contributor: fullname: Mazeron – volume: 21 start-page: 11767 year: 2015 end-page: 11776 ident: CR31 article-title: Colorectal cancer: metastases to a single organ publication-title: World J Gastroenterol doi: 10.3748/wjg.v21.i41.11767 contributor: fullname: Karapetis – volume: 121 start-page: 1195 year: 2015 end-page: 1203 ident: CR12 article-title: RAS mutations affect pattern of metastatic spread and increase propensity for brain metastasis in colorectal cancer publication-title: Cancer doi: 10.1002/cncr.29196 contributor: fullname: Kemeny – volume: 84 start-page: 69 year: 2017 end-page: 80 ident: CR18 article-title: Understanding the role of primary tumour localisation in colorectal cancer treatment and outcomes publication-title: Eur J Cancer doi: 10.1016/j.ejca.2017.07.016 contributor: fullname: Thiebach – volume: 14 start-page: 281 year: 2015 end-page: 290 ident: CR9 article-title: Brain metastasis in colorectal cancer patients: survival and analysis of prognostic factors publication-title: Clin Colorectal Cancer doi: 10.1016/j.clcc.2015.05.009 contributor: fullname: Heinemann – volume: 37 start-page: 745 year: 1997 end-page: 751 ident: CR13 article-title: Analysis ( Rpa ) of prognostic factors therapy oncology group ( Rtog ) trials publication-title: Radiat Oncol contributor: fullname: Rotman – volume: 8 start-page: 55 year: 2017 end-page: 63 ident: CR5 article-title: Clinical characteristics and treatment outcomes of patients with colorectal cancer who develop brain metastasis: a single institution experience publication-title: J Gastrointest Oncol doi: 10.21037/jgo.2016.12.11 contributor: fullname: Mahalingam – volume: 13 start-page: 135 issue: 2 year: 2017 end-page: 144 ident: CR25 article-title: Comparison of the molecular profile of brain metastases from colorectal cancer and corresponding primary tumors publication-title: Future Oncol doi: 10.2217/fon-2016-0196 contributor: fullname: De Maglio – volume: 31 year: 2014 ident: CR3 article-title: The clinical and pathological features of 133 colorectal cancer patients with brain metastasis: a multicenter retrospective analysis of the Gastrointestinal Tumors Working Committee of the Turkish Oncology Group (TOG) publication-title: Med Oncol doi: 10.1007/s12032-014-0152-z contributor: fullname: Ilis-Temiz – volume: 13 start-page: 226 year: 2014 end-page: 231 ident: CR11 article-title: Prognostic factors for patients with advanced colorectal cancer and symptomatic brain metastases publication-title: Clin Color Cancer doi: 10.1016/j.clcc.2014.09.008 contributor: fullname: Sugiura – volume: 15 start-page: 768 year: 2014 end-page: 776 ident: CR15 article-title: Characterization of rare transforming KRAS mutations in sporadic colorectal cancer publication-title: Cancer Biol Ther doi: 10.4161/cbt.28550 contributor: fullname: To – volume: 56 start-page: 639 year: 2017 end-page: 645 ident: CR10 article-title: Risk factors for brain metastases in patients with metastatic colorectal cancer publication-title: Acta Oncol doi: 10.1080/0284186X.2017.1290272 contributor: fullname: Nielsen – volume: 30 start-page: 10 year: 2011 ident: CR2 article-title: Brain metastases from solid tumors: disease outcome according to type of treatment and therapeutic resources of the treating center publication-title: J Exp Clin Cancer Res doi: 10.1186/1756-9966-30-10 contributor: fullname: Carapella – volume: 184 start-page: 673 year: 2015 end-page: 675 ident: CR7 article-title: Brain metastasis from colorectal carcinoma: a single cancer centre experience publication-title: Ir J Med Sci doi: 10.1007/s11845-015-1272-y contributor: fullname: Winter – volume: 8 start-page: 100 year: 2009 end-page: 105 ident: CR23 article-title: Brain metastases from colorectal cancer: risk factors, incidence, and the possible role of chemokines publication-title: Clin Color Cancer doi: 10.3816/CCC.2009.n.016 contributor: fullname: Pipas – volume: 21 start-page: 847 year: 2017 ident: 3107_CR14 publication-title: Tech Coloproctol doi: 10.1007/s10151-017-1707-8 contributor: fullname: IL Silva – volume: 67 start-page: 7 year: 2017 ident: 3107_CR1 publication-title: CA Cancer J Clin doi: 10.3322/caac.21387 contributor: fullname: RL Siegel – volume: 3 start-page: 1 year: 2016 ident: 3107_CR20 publication-title: Jama Oncol doi: 10.1001/jamaoncol.2016.4227 contributor: fullname: MD Fausto Petrelli – volume: 18 start-page: 88 year: 2016 ident: 3107_CR27 publication-title: Clin Transl Oncol doi: 10.1007/s12094-015-1340-9 contributor: fullname: C Nieder – volume: 8 start-page: 100 year: 2009 ident: 3107_CR23 publication-title: Clin Color Cancer doi: 10.3816/CCC.2009.n.016 contributor: fullname: JP Mongan – volume: 106 start-page: 144 year: 2012 ident: 3107_CR6 publication-title: J Surg Oncol doi: 10.1002/jso.23055 contributor: fullname: S Noura – volume: 84 start-page: 69 year: 2017 ident: 3107_CR18 publication-title: Eur J Cancer doi: 10.1016/j.ejca.2017.07.016 contributor: fullname: S Stintzing – volume: 121 start-page: 1195 year: 2015 ident: 3107_CR12 publication-title: Cancer doi: 10.1002/cncr.29196 contributor: fullname: R Yaeger – volume: 88 start-page: 140 year: 2017 ident: 3107_CR28 publication-title: ANZ J Surg doi: 10.1111/ans.14107 contributor: fullname: D Mege – volume: 14 start-page: 281 year: 2015 ident: 3107_CR9 publication-title: Clin Colorectal Cancer doi: 10.1016/j.clcc.2015.05.009 contributor: fullname: M Michl – volume: 29 start-page: 201 year: 2014 ident: 3107_CR21 publication-title: Int J Color Dis doi: 10.1007/s00384-013-1781-y contributor: fullname: E Magni – volume: 184 start-page: 673 year: 2015 ident: 3107_CR7 publication-title: Ir J Med Sci doi: 10.1007/s11845-015-1272-y contributor: fullname: R Tevlin – volume: 17 start-page: 2545 year: 2016 ident: 3107_CR19 publication-title: Asian Pacific J Cancer Prev doi: 10.7314/APJCP.2016.17.4.2545 contributor: fullname: M Hussain – volume: 37 start-page: 745 year: 1997 ident: 3107_CR13 publication-title: Radiat Oncol contributor: fullname: L Gaspar – volume: 25 start-page: 1995 year: 2014 ident: 3107_CR16 publication-title: Ann Oncol doi: 10.1093/annonc/mdu275 contributor: fullname: E Missiaglia – volume: 56 start-page: 639 year: 2017 ident: 3107_CR10 publication-title: Acta Oncol doi: 10.1080/0284186X.2017.1290272 contributor: fullname: TD Christensen – volume: 31 year: 2014 ident: 3107_CR3 publication-title: Med Oncol doi: 10.1007/s12032-014-0152-z contributor: fullname: O Tanriverdi – volume: 13 start-page: 226 year: 2014 ident: 3107_CR11 publication-title: Clin Color Cancer doi: 10.1016/j.clcc.2014.09.008 contributor: fullname: T Tokoro – volume: 15 start-page: 768 year: 2014 ident: 3107_CR15 publication-title: Cancer Biol Ther doi: 10.4161/cbt.28550 contributor: fullname: JHM Tong – volume: 7 year: 2017 ident: 3107_CR17 publication-title: Sci Rep doi: 10.1038/s41598-017-08413-z contributor: fullname: XH Gao – volume: 18 start-page: 97 year: 2014 ident: 3107_CR30 publication-title: Cancer/Radiotherapie doi: 10.1016/j.canrad.2013.12.003 contributor: fullname: L Feuvret – volume: 93 start-page: 309 year: 2017 ident: 3107_CR24 publication-title: Oncology doi: 10.1159/000478661 contributor: fullname: H Nozawa – volume: 30 start-page: 10 year: 2011 ident: 3107_CR2 publication-title: J Exp Clin Cancer Res doi: 10.1186/1756-9966-30-10 contributor: fullname: A Fabi – volume: 57 start-page: 56 issue: 1 year: 2014 ident: 3107_CR8 publication-title: Diseases of the Colon & Rectum doi: 10.1097/01.dcr.0000436998.30504.98 contributor: fullname: Yozo Suzuki – volume: 75 start-page: 1132 year: 2009 ident: 3107_CR29 publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/j.ijrobp.2008.12.031 contributor: fullname: N Kased – volume: 8 start-page: 55 year: 2017 ident: 3107_CR5 publication-title: J Gastrointest Oncol doi: 10.21037/jgo.2016.12.11 contributor: fullname: C Fountzilas – volume: 113 start-page: 158 year: 2008 ident: 3107_CR4 publication-title: Cancer doi: 10.1002/cncr.23531 contributor: fullname: TJ Kruser – volume: 101 start-page: 49 year: 2011 ident: 3107_CR26 publication-title: J Neuro-Oncol doi: 10.1007/s11060-010-0214-9 contributor: fullname: M Jung – volume: 18 start-page: 93 year: 2016 ident: 3107_CR22 publication-title: Clin Transl Oncol doi: 10.1007/s12094-015-1341-8 contributor: fullname: L Lin – volume: 21 start-page: 11767 year: 2015 ident: 3107_CR31 publication-title: World J Gastroenterol doi: 10.3748/wjg.v21.i41.11767 contributor: fullname: S Vatandoust – volume: 13 start-page: 135 issue: 2 year: 2017 ident: 3107_CR25 publication-title: Future Oncol doi: 10.2217/fon-2016-0196 contributor: fullname: G Aprile |
SSID | ssj0017674 |
Score | 2.32439 |
Snippet | Purpose
Colorectal cancer (CRC) brain metastases (BM) are an uncommon and late event. We aim to investigate the impact of clinical factors, treatment... Colorectal cancer (CRC) brain metastases (BM) are an uncommon and late event. We aim to investigate the impact of clinical factors, treatment modalities and... Purpose Colorectal cancer (CRC) brain metastases (BM) are an uncommon and late event. We aim to investigate the impact of clinical factors, treatment... PurposeColorectal cancer (CRC) brain metastases (BM) are an uncommon and late event. We aim to investigate the impact of clinical factors, treatment modalities... PURPOSEColorectal cancer (CRC) brain metastases (BM) are an uncommon and late event. We aim to investigate the impact of clinical factors, treatment modalities... |
SourceID | proquest gale crossref pubmed springer |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 1517 |
SubjectTerms | Adult Aged Aged, 80 and over Analysis Brain cancer Brain Neoplasms - secondary Care and treatment Colorectal cancer Colorectal carcinoma Colorectal Neoplasms - diagnosis Colorectal Neoplasms - pathology Diagnosis Female Gastroenterology Hepatology Homeopathy Humans Internal Medicine Male Materia medica and therapeutics Medical prognosis Medicine Medicine & Public Health Metastases Metastasis Middle Aged Original Article Patient outcomes Patients Proctology Prognosis Radiation therapy Surgery Survival Survival Analysis Therapeutics Time Factors Young Adult |
Title | Brain metastases in colorectal cancer: prognostic factors and survival analysis |
URI | https://link.springer.com/article/10.1007/s00384-018-3107-6 https://www.ncbi.nlm.nih.gov/pubmed/29943356 https://www.proquest.com/docview/2058844070 https://search.proquest.com/docview/2059549741 |
Volume | 33 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT8MwDLZgkxAX3o_BQEVCQgIVlaZZU24DNk2IxwGQuEVpHhdEh9bt_2N3bWETHOAY5dE0tmM7Tj4DHAcpcoYJja-Vi3z0NwKUOZ34TDjjHDcsNkXqhKf44VXc9AgmJ6yPLrK38yoiWWzU9Vs3imHRhQk6zgtiv7MITVQ9HHm72e3dDu7q2AHB0xQXF-PEJyiVKpb50yAz2mh-T_6mlOaipIXy6a_-Z9prsFKaml53yhvrsGCzDVi6L4Ppm_B4RekhvHc7Vmgi5jb3sEQg1rQJYkdNDDG69OgKVzYkPGevzM7jqcx4-QR3GeRTLExxTbbgpd97vh74ZX4FX6MZMvZFSh5qEnKUc2V4lHKG1h2zljEnCKjeurjDE4M2W5iiatfCKNW5cNYm3DpstQ2NbJjZXfCcQ0NQGMu5CKNUo9eFpOYanZFUiUSrFpxW6yw_pjAasgZMLpZI4hJJWiLZacEJUUKSiI1HSqvypQB-isCqZDdGL1AIFgUtaM-0RNHQs9UVLWUpmrkMA3qbi34sVh_V1dSTrptldjgp2lD4E62tFuxMeaCeNurviDGOszyrKP41-K__tPen1vuwHBLLFG8e29AYjyb2ABZzMzksuf0TFUv2Vg |
link.rule.ids | 315,782,786,27933,27934,41073,42142,48344,48347,48357,49649,49652,49662,52153 |
linkProvider | Springer Nature |
linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ZT8MwDLZgSMAL9zHOIiEhgSqVpllT3sYlEDAeGBI8RWmONzq0bv8fuxcMwQM8RjmaOnZsx84XgMMgRc4wofG1cpGP_kaAMqcTnwlnnOOGxaZ4OuEp7r2IyyuCyWH1XZgi270OSRY7dXPZjYJYlDFB53lB7HemYYbAzsMWzHRfXl8vm-AB4dMUmYtx4hOWSh3M_GmQCXX0fVP-opW-hUkL7XO9-K95L8FCZWx63ZI7lmHKZisw-1CF01fh8ZweiPDe7EihkZjb3MMSwVjTNogdNbHE8MyjJK5sQIjOXvU-j6cy4-Vj3GeQU7FQIpuswfP1Vf_ixq9eWPA1GiIjX6TkoyYhR0lXhkcpZ2jfMWsZc4Kg6q2LOzwxaLWFKSp3LYxSnVNnbcKtw1br0MoGmd0Ezzk0BYWxnIswSjX6XbjYXKM7kiqRaNWG45rQ8r0E0pANZHJBIokkkkQi2WnDES2FJCEbDZVW1V0B_BTBVclujH6gECwK2rAz0RKFQ09W14spK-HMZRjQ7Vz0ZLH6oKmmnpRwltnBuGhDAVC0t9qwUTJBM23U4BFjHGd5Uq_45-C__tPWn1rvw9xN_-Fe3t_27rZhvjxRpoOfHWiNhmO7C9O5Ge9VrP8BQmP6hQ |
linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1ZS8RADA66gvjifaxnBUFQyta2s536IuuxKp6ggm_DdI43u7Lt_n-TXrqiD-JjmaNzJJNkknwDsOclSBna166SNnTR3vCQ51TsBtxqa5kOIl08nfAU3b_y8wuCyTmpc2GKaPfaJVnmNBBKU5p33rXtNIlv5NCi6Am62_MitzsJU3QrFrZgqnf9fNlvHAmEVVNEMUaxS7gqtWPzp07GRNP3A_qLhPrmMi0kUX_u33OYh9lKCXV6JdUswIRJF2H6rnKzL8HDKT0c4byZXKLymJnMwS-Ct6bjERsqIpXhsUPBXemAkJ6d6t0eR6bayUZ4_iAF40eJeLIML_2L57Mrt3p5wVWooOQuT8h2jX2GJ4DULExYgHpfYEwQWE4Q9sZGXRZr1Ob8BIW-4lrK7pE1JmbGYq0VaKWD1KyBYy2qiFwbxrgfJgrtMSQCptBMSSSPlWzDQb3o4r0E2BANlHKxRAKXSNASiW4b9mlbBDFfPpRKVjkE-CuCsRK9CO1DjoTgtWFzrCYyjRovrjdWVEybCd-jrF20cLF4tymmlhSIlprBqKhDjlHUw9qwWhJEM2yU7GEQMBzlYb37n53_Oqf1P9XegenH8764vb6_2YAZn6inSIzchFY-HJktmMz0aLvigg8SzQMu |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Brain+metastases+in+colorectal+cancer%3A+prognostic+factors+and+survival+analysis&rft.jtitle=International+journal+of+colorectal+disease&rft.au=Del+Carpio+Huerta%2C+Luis&rft.au=Virgili+Manrique%2C+Anna+Cristina&rft.au=Szafranska%2C+Justyna&rft.au=Martin-Richard%2C+Marta&rft.date=2018-11-01&rft.pub=Springer+Berlin+Heidelberg&rft.issn=0179-1958&rft.eissn=1432-1262&rft.volume=33&rft.issue=11&rft.spage=1517&rft.epage=1523&rft_id=info:doi/10.1007%2Fs00384-018-3107-6&rft.externalDocID=10_1007_s00384_018_3107_6 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0179-1958&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0179-1958&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0179-1958&client=summon |